Trevi Therapeutics, Inc.(Pending) | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

Latest Posts

About This Stock More About This Stock
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
Article By: Benzinga
Friday, November 1, 2019 7:38 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours.
In this article: AMGN, BGNE, MNK, PRTK, IDYA, CDNA, BLUE Also: HOTH, AGN, AZN, BMY, GSK, RMD, ACOR, ACRX, ALIM, AMAG, BCRX, CERS, IMGN, NURO, RMTI, CELG, VRTX, ABBV, AGIO, REPH, RETA, PRTO, MGNX, OPGN, MGEN, DOVA, DRNA, DCPH, TRVI, OYST, RAPT, ARDS, MIRM, ITRM, COCP, CYCN, GMAB
Read
IPOs – Where Good Money Goes To Die
Article By: Bespoke Investment Group
Thursday, October 10, 2019 4:36 PM EDT
While it’s been a frustrating year for most investors, IPOs haven’t been a bright spot.
In this article: BYND, GNLN, FSLY, CRWD, HOOK, TRVI, KLDO, ZM, SWAV
Read

Latest Tweets for $TRVI

No tweets yet!

PARTNER HEADLINES